New, innovative medicines to become available for Hungarian patients

Following more than two years of groundwork, the Hungarian government’s health department has decided about the inclusion of 29 new, innovative medicines and their indications into subsidy, affecting several therapeutic fields, providing the most effective treatment for the illnesses concerned, according to the latest issue of the Hungarian Official Journal.

The Association of Innovative Pharmaceutical Manufacturers (AIPM) welcomes this decision regarding the inclusion of the largest number of medicines in years, and trusts that the medicinal products will reach the patients as soon as possible, following the necessary public procurement procedures. In order to ensure that Hungarian patients would not have to wait for so long for the inclusion of medicinal products in the future, the AIPM turns to the government with further professional recommendations.

Dr Péter Holchacker, the director of the AIPM, welcomed the decision, as it makes new and advanced therapies widely available for Hungarian patients to an extent not seen for years. However, in order to realise this, it is also necessary to promptly call for bids, and initiate the public procurement procedures necessary for certain medicinal products, otherwise further delays may be expected regarding their actual availability.